Jw Pharmac - Asset Resilience Ratio

Latest as of March 2026: 7.36%

Jw Pharmac (001060) has an Asset Resilience Ratio of 7.36% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Jw Pharmac to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩45.77 Billion

≈ $31.02 Million USD Cash + Short-term Investments

Total Assets

₩621.61 Billion

≈ $421.25 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Jw Pharmac's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Jw Pharmac's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Jw Pharmac's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Jw Pharmac (001060) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩45.77 Billion	7.36%
Total Liquid Assets	₩45.77 Billion	7.36%

Asset Resilience Insights

Limited Liquidity: Jw Pharmac maintains only 7.36% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jw Pharmac Industry Peers by Asset Resilience Ratio

Compare Jw Pharmac's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Jw Pharmac (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Jw Pharmac.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	3.65%	₩22.11 Billion ≈ $14.98 Million	₩605.27 Billion ≈ $410.18 Million	-0.01pp
2024-12-31	3.66%	₩22.12 Billion ≈ $14.99 Million	₩604.60 Billion ≈ $409.73 Million	-8.48pp
2023-12-31	12.14%	₩78.29 Billion ≈ $53.05 Million	₩645.04 Billion ≈ $437.13 Million	-6.30pp
2022-12-31	18.44%	₩115.78 Billion ≈ $78.46 Million	₩627.97 Billion ≈ $425.57 Million	+13.34pp
2021-12-31	5.10%	₩32.30 Billion ≈ $21.89 Million	₩633.05 Billion ≈ $429.01 Million	-3.06pp
2020-12-31	8.17%	₩44.84 Billion ≈ $30.39 Million	₩549.09 Billion ≈ $372.11 Million	+8.16pp
2016-12-31	0.00%	₩20.00 Million ≈ $13.55K	₩651.08 Billion ≈ $441.23 Million	0.00pp
2015-12-31	0.00%	₩30.00 Million ≈ $20.33K	₩613.48 Billion ≈ $415.75 Million	-0.12pp
2014-12-31	0.12%	₩730.73 Million ≈ $495.20K	₩594.12 Billion ≈ $402.63 Million	-0.19pp
2013-12-31	0.31%	₩1.83 Billion ≈ $1.24 Million	₩589.37 Billion ≈ $399.41 Million	+0.05pp
2012-12-31	0.26%	₩1.58 Billion ≈ $1.07 Million	₩603.15 Billion ≈ $408.74 Million	+0.07pp
2011-12-31	0.20%	₩1.31 Billion ≈ $889.81K	₩667.09 Billion ≈ $452.08 Million	-3.66pp
2006-12-31	3.86%	₩19.89 Billion ≈ $13.48 Million	₩515.85 Billion ≈ $349.58 Million	-1.49pp
2005-12-31	5.35%	₩25.57 Billion ≈ $17.33 Million	₩477.97 Billion ≈ $323.91 Million	-0.45pp
2004-12-31	5.80%	₩26.55 Billion ≈ $17.99 Million	₩457.56 Billion ≈ $310.08 Million	-6.04pp
2003-12-31	11.84%	₩48.78 Billion ≈ $33.06 Million	₩412.00 Billion ≈ $279.21 Million	+5.83pp
2002-12-31	6.02%	₩23.19 Billion ≈ $15.72 Million	₩385.60 Billion ≈ $261.32 Million	-0.66pp
2001-12-31	6.68%	₩25.73 Billion ≈ $17.43 Million	₩385.28 Billion ≈ $261.10 Million	-2.16pp
2000-12-31	8.84%	₩35.14 Billion ≈ $23.81 Million	₩397.46 Billion ≈ $269.35 Million	--

pp = percentage points

About Jw Pharmac

KO:001060 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$426.35 Million

₩629.13 Billion KRW

Market Cap Rank

#13176 Global

#382 in Korea

Share Price

₩27900.00

Change (1 day)

+1.64%

52-Week Range

₩20950.00 - ₩39050.00

All Time High

₩75306.05